{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T15:11:33Z","timestamp":1781277093217,"version":"3.54.1"},"reference-count":46,"publisher":"American Academy of Pediatrics (AAP)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,1]]},"abstract":"<jats:p>Immune-mediated thrombocytopenia in neonates is caused by the transplacental passage of maternally derived antiplatelet antibodies. The 2 most common causes include neonatal alloimmune thrombocytopenia, which leads to significant thrombocytopenia and risk of intracranial hemorrhage, and autoimmune thrombocytopenia, which is generally less severe. No specific guidelines for prenatal management exist for either disease; however, intravenous immune globulin treatments and systemic steroids for women with at-risk pregnancies can be useful in both diseases. In this review, we discuss the current literature and management strategies for both pregnant women and newborns with immune-mediated thrombocytopenia.<\/jats:p>","DOI":"10.1542\/neo.23-7-e462","type":"journal-article","created":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T03:04:55Z","timestamp":1656644695000},"page":"e462-e471","source":"Crossref","is-referenced-by-count":7,"title":["Immune-Mediated Neonatal Thrombocytopenia"],"prefix":"10.1542","volume":"23","author":[{"given":"Emily","family":"Batton","sequence":"first","affiliation":[{"name":"*Division of Neonatology, Department of Pediatrics, University of California San Diego-Rady Children\u2019s Hospital, San Diego, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra L.","family":"Leibel","sequence":"additional","affiliation":[{"name":"*Division of Neonatology, Department of Pediatrics, University of California San Diego-Rady Children\u2019s Hospital, San Diego, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2022,7,1]]},"reference":[{"key":"2022070103042573400_B1","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/B978-0-323-53045-3.00047-7","article-title":"Thrombocytopenia and thrombocytosis","volume-title":"Rodak\u2019s Hematology","author":"DeChristopher","year":"2020","edition":"6th ed."},{"issue":"3","key":"2022070103042573400_B2","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0095-5108(05)70044-0","article-title":"Evaluation and treatment of thrombocytopenia in the neonatal intensive care unit","volume":"27","author":"Sola","year":"2000","journal-title":"Clin Perinatol"},{"issue":"2","key":"2022070103042573400_B3","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/jp.2008.141","article-title":"Platelet reference ranges for neonates, defined using data from over 47,000 patients in a multihospital healthcare system","volume":"29","author":"Wiedmeier","year":"2009","journal-title":"J Perinatol"},{"issue":"2","key":"2022070103042573400_B4","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0095-5108(18)30924-2","article-title":"Neonatal thrombocytopenia","volume":"11","author":"Andrew","year":"1984","journal-title":"Clin Perinatol"},{"issue":"5","key":"2022070103042573400_B5","doi-asserted-by":"crossref","first-page":"e826","DOI":"10.1542\/peds.2009-0332","article-title":"Prospective, observational study of outcomes in neonates with severe thrombocytopenia","volume":"124","author":"Stanworth","year":"2009","journal-title":"Pediatrics"},{"issue":"6","key":"2022070103042573400_B6","doi-asserted-by":"crossref","first-page":"e1095","DOI":"10.1542\/peds.2009-0582","article-title":"Severe thrombocytopenia in the NICU","volume":"124","author":"Baer","year":"2009","journal-title":"Pediatrics"},{"issue":"1","key":"2022070103042573400_B7","first-page":"e15","article-title":"Fetal and neonatal alloimmune thrombocytopenia","volume":"6","author":"Espinoza","year":"2013","journal-title":"Rev Obstet Gynecol"},{"issue":"20","key":"2022070103042573400_B8","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1056\/NEJM199311113292005","article-title":"Fetal thrombocytopenia and its relation to maternal thrombocytopenia","volume":"329","author":"Burrows","year":"1993","journal-title":"N Engl J Med"},{"issue":"1","key":"2022070103042573400_B9","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJM199707033370104","article-title":"Fetal alloimmune thrombocytopenia","volume":"337","author":"Bussel","year":"1997","journal-title":"N Engl J Med"},{"issue":"4","key":"2022070103042573400_B10","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1365-2141.2010.08540.x","article-title":"The incidence and outcomes of fetomaternal alloimmune thrombocytopenia: a UK national study using three data sources","volume":"152","author":"Knight","year":"2011","journal-title":"Br J Haematol"},{"key":"2022070103042573400_B11","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1542\/neo.14-2-e74","article-title":"Neonatal thrombocytopenia","volume":"14","author":"Fern\u00e1ndez","year":"2013","journal-title":"NeoReviews"},{"issue":"4","key":"2022070103042573400_B12","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1542\/peds.2013-3320","article-title":"Incidence and consequences of neonatal alloimmune thrombocytopenia: a systematic review","volume":"133","author":"Kamphuis","year":"2014","journal-title":"Pediatrics"},{"issue":"10","key":"2022070103042573400_B13","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1111\/j.1537-2995.2008.01832.x","article-title":"Ultrastructural localization of glycoprotein IIIa (GPIIIa, beta 3 integrin) on placental syncytiotrophoblast microvilli: implications for platelet alloimmunization during pregnancy","volume":"48","author":"Kumpel","year":"2008","journal-title":"Transfusion"},{"issue":"3","key":"2022070103042573400_B14","doi-asserted-by":"crossref","first-page":"e002490","DOI":"10.1136\/bmjopen-2012-002490","article-title":"Fetal intracranial haemorrhages caused by fetal and neonatal alloimmune thrombocytopenia: an observational cohort study of 43 cases from an international multicentre registry","volume":"3","author":"Tiller","year":"2013","journal-title":"BMJ Open"},{"issue":"12","key":"2022070103042573400_B15","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1111\/jth.14294","article-title":"Investigations for fetal and neonatal alloimmune thrombocytopenia: communication from the SSC of the ISTH","volume":"16","author":"Petermann","year":"2018","journal-title":"J Thromb Haemost"},{"issue":"11","key":"2022070103042573400_B16","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/pd.1970121116","article-title":"Neonatal alloimmune thrombocytopenia due to anti-P1A1 (anti-HPA-1a): importance of paternal and fetal platelet typing for assessment of fetal risk","volume":"12","author":"Lipitz","year":"1992","journal-title":"Prenat Diagn"},{"issue":"1","key":"2022070103042573400_B17","doi-asserted-by":"crossref","first-page":"102708","DOI":"10.1016\/j.transci.2019.102708","article-title":"Recent advances in non-invasive fetal HPA-1a typing","volume":"59","author":"Nogu\u00e9s","year":"2020","journal-title":"Transfus Apheresis Sci"},{"issue":"11","key":"2022070103042573400_B18","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1182\/blood-2016-10-739656","article-title":"Antenatal management in fetal and neonatal alloimmune thrombocytopenia: a systematic review","volume":"129","author":"Winkelhorst","year":"2017","journal-title":"Blood"},{"issue":"4","key":"2022070103042573400_B19","doi-asserted-by":"crossref","first-page":"471.e1","DOI":"10.1016\/j.ajog.2016.04.033","article-title":"Omission of fetal sampling in treatment of subsequent pregnancies in fetal-neonatal alloimmune thrombocytopenia","volume":"215","author":"Lakkaraja","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"2 pt 1","key":"2022070103042573400_B20","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/01.AOG.0000270302.80336.dd","article-title":"Antepartum treatment without early cordocentesis for standard-risk alloimmune thrombocytopenia: a randomized controlled trial","volume":"110","author":"Berkowitz","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"2","key":"2022070103042573400_B21","doi-asserted-by":"crossref","first-page":"135.e1","DOI":"10.1016\/j.ajog.2010.03.011","article-title":"Intracranial hemorrhage in alloimmune thrombocytopenia: stratified management to prevent recurrence in the subsequent affected fetus","volume":"203","author":"Bussel","year":"2010","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"2022070103042573400_B22","first-page":"CD004226","article-title":"Antenatal interventions for fetomaternal alloimmune thrombocytopenia","author":"Rayment","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"2022070103042573400_B23","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/pbc.20282","article-title":"Clinical and diagnostic comparison of neonatal alloimmune thrombocytopenia to non-immune cases of thrombocytopenia","volume":"45","author":"Bussel","year":"2005","journal-title":"Pediatr Blood Cancer"},{"key":"2022070103042573400_B24","unstructured":"Bellone M , LouieJ. Fetal and neonatal alloimmune thrombocytopenia: a case presentation and review. BBANYS Q. 2014;47:3\u20136https:\/\/www.researchgate.net\/publication\/ 261653896_Fetal_and_Neonatal_Alloimmune_Thrombocytopenia_ A_Case_Presentation_and_Review"},{"issue":"5","key":"2022070103042573400_B25","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/1471-0528.13343","article-title":"True risk of fetal\/neonatal alloimmune thrombocytopenia in subsequent pregnancies: a prospective observational follow-up study","volume":"123","author":"Tiller","year":"2016","journal-title":"BJOG"},{"issue":"4","key":"2022070103042573400_B26","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/00043426-198624000-00008","article-title":"In utero cerebral hemorrhage in alloimmune thrombocytopenia","volume":"8","author":"Herman","year":"1986","journal-title":"Am J Pediatr Hematol Oncol"},{"issue":"12","key":"2022070103042573400_B27","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/pbc.26690","article-title":"Imaging and management of fetuses and neonates with alloimmune thrombocytopenia","volume":"64","author":"Kovanlikaya","year":"2017","journal-title":"Pediatr Blood Cancer"},{"issue":"10","key":"2022070103042573400_B28","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/s41372-019-0360-7","article-title":"Postnatal intervention for the treatment of FNAIT: a systematic review","volume":"39","author":"Baker","year":"2019","journal-title":"J Perinatol"},{"issue":"9","key":"2022070103042573400_B29","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1182\/blood-2005-06-2235","article-title":"Antigen-positive platelet transfusion in neonatal alloimmune thrombocytopenia (NAIT)","volume":"107","author":"Kiefel","year":"2006","journal-title":"Blood"},{"issue":"1","key":"2022070103042573400_B30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1053\/j.semperi.2008.10.003","article-title":"Current approaches to the evaluation and management of the fetus and neonate with immune thrombocytopenia","volume":"33","author":"Bussel","year":"2009","journal-title":"Semin Perinatol"},{"issue":"3","key":"2022070103042573400_B31","doi-asserted-by":"crossref","first-page":"F173","DOI":"10.1136\/fn.82.3.F173","article-title":"Management of severe alloimmune thrombocytopenia in the newborn","volume":"82","author":"Ouwehand","year":"2000","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"2022070103042573400_B32","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1538-7836.2009.03380.x","article-title":"Diagnosis and management of the fetus and neonate with alloimmune thrombocytopenia","volume":"7","author":"Bussel","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"3","key":"2022070103042573400_B33","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/vox.12036","article-title":"Outcome and management in neonatal thrombocytopenia due to maternal idiopathic thrombocytopenic purpura","volume":"105","author":"van der Lugt","year":"2013","journal-title":"Vox Sang"},{"issue":"12","key":"2022070103042573400_B34","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/00006254-199312000-00003","article-title":"Pregnancy in patients with idiopathic thrombocytopenic purpura: assessing the risks for the infant at delivery","volume":"48","author":"Burrows","year":"1993","journal-title":"Obstet Gynecol Surv"},{"issue":"5","key":"2022070103042573400_B35","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/1471-0528.14697","article-title":"Severe primary autoimmune thrombocytopenia in pregnancy: a national cohort study","volume":"125","author":"Care","year":"2018","journal-title":"BJOG"},{"issue":"3","key":"2022070103042573400_B36","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/ajh.21616","article-title":"The incidence of immune thrombocytopenic purpura in children and adults: a critical review of published reports","volume":"85","author":"Terrell","year":"2010","journal-title":"Am J Hematol"},{"issue":"13","key":"2022070103042573400_B37","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1182\/blood-2002-10-3317","article-title":"A retrospective 11-year analysis of obstetric patients with idiopathic thrombocytopenic purpura","volume":"102","author":"Webert","year":"2003","journal-title":"Blood"},{"issue":"16","key":"2022070103042573400_B38","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1182\/blood-2010-08-302984","article-title":"The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia","volume":"117","author":"Neunert","year":"2011","journal-title":"Blood"},{"issue":"11","key":"2022070103042573400_B39","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1182\/blood-2008-07-162503","article-title":"Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group","volume":"113","author":"Rodeghiero","year":"2009","journal-title":"Blood"},{"issue":"10","key":"2022070103042573400_B40","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1182\/blood-2016-04-710285","article-title":"Corticosteroids compared with intravenous immunoglobulin for the treatment of immune thrombocytopenia in pregnancy","volume":"128","author":"Sun","year":"2016","journal-title":"Blood"},{"issue":"5","key":"2022070103042573400_B41","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1182\/blood-2014-12-614446","article-title":"Persistent neonatal thrombocytopenia can be caused by IgA antiplatelet antibodies in breast milk of immune thrombocytopenic mothers","volume":"126","author":"Hauschner","year":"2015","journal-title":"Blood"},{"issue":"2","key":"2022070103042573400_B42","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1046\/j.1365-2141.1998.01006.x","article-title":"Relationships between severe neonatal thrombocytopenia and maternal characteristics in pregnancies associated with autoimmune thrombocytopenia","volume":"103","author":"Valat","year":"1998","journal-title":"Br J Haematol"},{"issue":"1","key":"2022070103042573400_B43","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0002-9378(97)70454-X","article-title":"Maternal characteristics and risk of severe neonatal thrombocytopenia and intracranial hemorrhage in pregnancies complicated by autoimmune thrombocytopenia","volume":"177","author":"Payne","year":"1997","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"2022070103042573400_B44","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1182\/blood-2009-06-225565","article-title":"International consensus report on the investigation and management of primary immune thrombocytopenia","volume":"115","author":"Provan","year":"2010","journal-title":"Blood"},{"issue":"21","key":"2022070103042573400_B45","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1182\/blood-2017-05-781971","article-title":"Thrombocytopenia in pregnancy","volume":"130","author":"Cines","year":"2017","journal-title":"Blood"},{"key":"2022070103042573400_B46","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/GJTM.GJTM_21_20","article-title":"The utility of blood components in the care of sick neonates: an evidence-based review","volume":"5","author":"Gupta","year":"2020","journal-title":"Global J Transf Med"}],"container-title":["NeoReviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/neoreviews\/article-pdf\/23\/7\/e462\/1326203\/neoreviews.022022cmerev00020.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/neoreviews\/article-pdf\/23\/7\/e462\/1326203\/neoreviews.022022cmerev00020.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T00:46:14Z","timestamp":1700786774000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/neoreviews\/article\/23\/7\/e462\/188380\/Immune-Mediated-Neonatal-Thrombocytopenia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,1]]},"references-count":46,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7,1]]},"published-print":{"date-parts":[[2022,7,1]]}},"URL":"https:\/\/doi.org\/10.1542\/neo.23-7-e462","relation":{},"ISSN":["1526-9906"],"issn-type":[{"value":"1526-9906","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,1]]}}}